elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33376977-6452481D-8A6B-4E63-9992-BDB5F302331E
Q33376977-6452481D-8A6B-4E63-9992-BDB5F302331E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33376977-6452481D-8A6B-4E63-9992-BDB5F302331E
Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention.
P2860
Q33376977-6452481D-8A6B-4E63-9992-BDB5F302331E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33376977-6452481D-8A6B-4E63-9992-BDB5F302331E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9bd7e98f69aac1a9aa225cb7df81ecf449cde036
P2860
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reop